You are viewing: India Gastrointestinal Products Market analysis

The India Gastrointestinal Products Market was valued at $207.2 Million in 2024 and projected to reach to $308 Million by 2029, representing a compound annual growth rate of 8.2%. India's gastrointestinal products market is poised for sustained expansion through 2029, driven by demographic shifts, rising disposable incomes, and increased healthcare accessibility across tier-2 and tier-3 cities.

India Gastrointestinal Products Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Gastrointestinal Products Market Trends and Insights

  • This expansion reflects India's rising healthcare expenditure, increasing prevalence of digestive disorders, and growing consumer awareness of gastrointestinal health.
  • India's market growth rate of 8.2% CAGR significantly outpaces the global average of 6.1%, driven by a large population base, improving access to healthcare, and rising disposable incomes across urban and semi-urban regions. The gastrointestinal products market in India encompasses pharmaceuticals, dietary supplements, and medical devices targeting conditions such as acid reflux, irritable bowel syndrome, and inflammatory bowel disease.
  • India's pharmaceutical manufacturing capabilities and cost-effective production have positioned the country as a key player in the Asia Pacific region.
  • Between 2024 and 2029, India is expected to capture increasing market share as healthcare infrastructure improves and preventive care gains traction among consumers..

Key Market Statistics

  • CAGR (2024-2029) 8.2% CAGR
  • Market Size, 2024 ~USD 207.2 Million
  • Forecast, 2029 ~USD 308 Million
  • Country India

India Gastrointestinal Products Market Overview

Market Valuation Growth :

India's gastrointestinal products market is valued at USD 207.2 million in 2024, with a projected expansion to USD 308.0 million by 2029, representing a robust 8.2% CAGR that outpaces the global average of 6.1%.

Rising Healthcare Expenditure :

Increasing government healthcare spending and private sector investments in India are driving accessibility to gastrointestinal treatments, particularly in urban and semi-urban regions across the country.

Growing Disease Prevalence :

India faces escalating rates of digestive disorders including IBS, GERD, and inflammatory bowel diseases, driven by changing dietary patterns, urbanization, and lifestyle factors among the growing middle class.

Consumer Awareness Expansion :

Enhanced health consciousness and digital health literacy among Indian consumers are driving demand for preventive gastrointestinal products, supplements, and over-the-counter medications.

India Gastrointestinal Products Market Dynamics

  • The market benefits from a large population base experiencing lifestyle-related digestive disorders and growing preference for self-medication and preventive healthcare solutions.
  • Pharmaceutical companies and nutraceutical manufacturers are capitalizing on this opportunity through product innovation and direct-to-consumer marketing strategies tailored to Indian consumers. Government initiatives promoting healthcare infrastructure and digital health platforms are further accelerating market penetration.
  • The competitive landscape is intensifying with both multinational corporations and domestic players expanding their gastrointestinal product portfolios.
  • Regulatory support for pharmaceutical manufacturing and the growing e-commerce distribution channel are expected to enhance market accessibility, positioning India as a high-growth market within the Asia-Pacific gastrointestinal products sector..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • India's gastrointestinal products market is valued at USD 207.2 million in 2024 and is forecast to reach USD 308.0 million by 2029, representing an 8.2% CAGR.
    • India's market growth rate of 8.2% CAGR outpaces the global average of 6.1%, reflecting strong domestic demand and healthcare sector expansion.
    • Rising prevalence of digestive disorders, improved healthcare access, and increasing consumer awareness are key drivers of market growth in India.
    • India's robust pharmaceutical manufacturing base and cost-effective production capabilities position it as a competitive hub within the Asia Pacific gastrointestinal products market.

    Gastrointestinal Products Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment IRRITABLE BOWEL SYNDROME (IBS) (Disease)
    Forecast Period 2024-2029
    Growth Rate CAGR of 6.1% from 2024 to 2029
    Largest Segment ENDOSCOPY DEVICES (Device)
    Market Size Base Year (Billions) ~USD 14.65 (2024)
    Revenue Forecast (Billions) ~USD 19.7 (2029)
    Segments Covered Device, Type, Disease, End User

    India Gastrointestinal Products Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Device

    • Ablation Devices
    • Biopsy Devices
    • Endoscopy Devices
    • Motility Testing Devices
    • Other Gastroenterology/ Gastrointestinal Devices
    • Other Gastroenterology/Gastrointestinal Devices
    • Ph Monitoring Devices
    • Stenting Devices

    By Type

    • 4-Hour Ph Impedance Testing Devices
    • Ambulatory Ph Monitoring Systems
    • Anorectal Manometry Devices
    • Biliary Stents
    • Capsule Endoscopes
    • Colonic Stents
    • Cryoablation Devices
    • Duodenal Stents
    • Esophageal Manometry Devices
    • Esophageal Ph Monitoring Catheters
    • Esophageal Stents
    • Flexible Endoscopes
    • Gastric Balloons
    • Gastrointestinal Tubes
    • Hemorrhoid Treatment Devices
    • Laser Ablation Devices
    • Microwave Ablation Devices
    • Needle Biopsy Devices
    • Other Ablation Devices
    • Other Biopsy Devices
    • Other Endoscopy Devices
    • Other Motility Testing Devices
    • Pancreatic Stents
    • Radiofrequency Ablation Devices
    • Rigid Endoscopes
    • Wireless Ph Monitoring Capsules

    By Disease

    • Gastroesophageal Reflux Disease (Gerd)
    • Gastrointestinal Cancers
    • Inflammatory Bowel Disease (Ibd)
    • Irritable Bowel Syndrome (Ibs)
    • Other Diseases

    By End User

    • Ambulatory Surgical Centers & Independent Diagnostic Centers
    • Clinics
    • Hospitals
    • Other End Users

    INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS113.5120.7128.8137.6147157.2168.12009.2
    CLINICS49.151.153.55658.761.564.575.27.1
    HOSPITALS161.3173.1186.5201.2217.1234.4253.1238.85.1
    OTHER END USERS45.447.549.852.35557.860.871.17.4
    TOTAL369.3392.4418.6447.2477.9511546.5585.16.9

    Target Audience

    • Pharmaceutical Manufacturers : Pharmaceutical companies require India-specific market data to develop localized product portfolios, optimize pricing strategies, and identify distribution partnerships for gastrointestinal medications and treatments.
    • Nutraceutical & Supplement Companies : Nutraceutical businesses need detailed market insights on India's growing demand for digestive health supplements and preventive products to guide product innovation and market positioning strategies.
    • Healthcare Investors & Private Equity : Investment firms evaluating opportunities in India's healthcare sector require comprehensive market analysis to assess growth potential, competitive dynamics, and ROI prospects in the gastrointestinal products segment.
    • Medical Device Manufacturers : Device companies developing diagnostic and therapeutic gastrointestinal equipment need India-specific market data to understand adoption rates, regulatory requirements, and hospital procurement patterns.
    • Healthcare Consultants & Strategists : Consulting firms advising healthcare clients on India expansion strategies require detailed market intelligence on consumer behavior, competitive landscape, and growth drivers specific to gastrointestinal products.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise valuation data for India's gastrointestinal market (USD 207.2M in 2024) with 5-year forecasts, enabling accurate business planning and investment decisions specific to this high-growth emerging market.
    • Competitive Landscape Intelligence : Understand India-specific market dynamics, key players, and competitive positioning to identify market gaps and opportunities for product launches, partnerships, or market entry strategies in the gastrointestinal sector.
    • Consumer Behavior & Demand Insights : Access India-focused analysis of consumer preferences, purchasing patterns, and awareness levels regarding gastrointestinal health products to tailor marketing strategies and product development for Indian demographics.
    • Regulatory & Distribution Channel Analysis : Gain comprehensive understanding of India's pharmaceutical regulations, distribution networks, e-commerce penetration, and healthcare infrastructure to optimize go-to-market strategies and supply chain planning.
    • Strategic Growth Opportunities : Identify high-potential segments, emerging therapeutic areas, and geographic expansion opportunities within India's tier-2 and tier-3 cities to maximize market share and revenue growth through data-driven decision making.

    Frequently asked questions

    What is the current size of India's gastrointestinal products market?

    India's gastrointestinal products market was valued at USD 207.2 million in 2024 and is projected to grow to USD 308.0 million by 2029.

    What is the expected growth rate for India's gastrointestinal products market?

    India's gastrointestinal products market is expected to grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

    What factors are driving growth in India's gastrointestinal products market?

    Key growth drivers in India include rising healthcare expenditure, increasing prevalence of digestive disorders, growing consumer awareness, improved healthcare infrastructure, and rising disposable incomes in urban and semi-urban regions.

    How does India's gastrointestinal products market compare to global growth?

    India's market growth rate of 8.2% CAGR significantly outpaces the global average of 6.1%, indicating stronger domestic demand and market expansion potential.

    What products are included in India's gastrointestinal products market?

    India's gastrointestinal products market includes pharmaceuticals, dietary supplements, and medical devices targeting conditions such as acid reflux, irritable bowel syndrome, and inflammatory bowel disease.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the gastroenterology products market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Gastrointestinal Products Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Gastroenterology Products Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the gastrointestinal products market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market. the following is a breakdown of the primary respondents:

    Gastroenterology Products Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the gastrointestinal products market includes the following details. The market sizing of the market was undertaken from the global side.

    Country-Level Analysis

    The size of the gastrointestinal products market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall gastrointestinal products market was obtained from secondary data and validated by primary participants to arrive at the total gastroenterology products market. Primary participants further validated the numbers.

    Geographic Market Assessment (By Region & Country)

    • Approach 1:
      • Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends.
    • Approach 2:
      • Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews).

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Gastroenterology/Gastrointestinal Products Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Gastrointestinal Products Market Size: Bottom-Up Approach

    Global Gastrointestinal Products Market Size: Bottom-Up Approach

    Global Gastrointestinal Products Market Size: Top-Down Approach

    Global Gastrointestinal Products Market Size: Top-Down Approach

    To know about the assumptions considered for the study, Request for Free Sample Report

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the gastrointestinal products market.

    Market Definition

    Gastroenterology products encompass a variety of medical devices, diagnostic tools, and pharmaceuticals designed to diagnose, treat, and manage diseases and disorders of the gastrointestinal tract. These products include endoscopes, capsule endoscopy systems, ablation devices, stents, and specialized medications aimed at conditions like GERD, IBD, and colorectal cancer. Their purpose is to improve patient outcomes by offering advanced solutions for both diagnostic and therapeutic procedures within the GI tract.

    Key Stakeholders

    • Medical Device Manufacturers
    • Healthcare Institutions (hospitals and outpatient clinics)
    • Distributors and Suppliers
    • Research Institutes
    • Health Insurance Payers
    • Market Research and Consulting Firms

    Report Objectives

    • To define, describe, segment, and forecast the global gastrointestinal Products Market by devices, diseases end users, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall gastrointestinal products market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the gastroenterology products market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global gastrointestinal products market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the gastrointestinal products market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of each company

    Geographic Analysis

    • Further breakdown of the Latin American apheresis into specific countries and, the Middle East, and Africa apheresis into specific countries and further breakdown of the European apheresis into specific countries

    Get the Full Gastrointestinal Products Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Products Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status